KRSNAA563.45

Krsnaa Diagnostics Limited

· Pharma & Health
₹ CrorePeersSURAKSHAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,828 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment644.7667.4651.6651.6
+ Capital Work-in-Progress9.83.0208.1208.1
+ Other Intangibles2.42.94.84.8
+ Non-current Investments0.331.557.457.4
+ Other Non-current Financial Assets32.7118.335.935.9
Non-current Financial Assets33.0149.893.393.3
+ Deferred Tax Assets1.63.35.05.0
+ Other Non-current Assets59.140.6122.5122.5
Total Non-current Assets750.7867.11,085.41,085.4
Current Assets
+ Inventories35.829.526.726.7
+ Trade Receivables176.3277.7295.5295.5
+ Cash & Cash Equivalents2.43.830.230.2
+ Other Bank Balances51.264.6330.5330.5
+ Other Current Financial Assets143.128.331.331.3
Current Financial Assets372.9374.5687.5687.5
+ Other Current Assets12.510.524.124.1
Total Current Assets421.2414.5738.3738.3
Total Assets1,171.91,281.61,823.71,823.7
Equity
+ Equity Share Capital16.116.116.216.2
+ Other Equity / Reserves793.7866.6964.2964.2
Equity — Owners of Parent809.8882.8980.4980.4
Total Equity809.8882.8980.4980.4
Liabilities
+ Borrowings — Non-current41.947.2468.3468.3
+ Other Non-current Financial Liab20.620.866.666.6
Non-current Financial Liabilities62.468.0534.9534.9
+ Provisions — Non-current1.82.93.23.2
+ Deferred Tax Liabilities16.422.630.030.0
Non-current Liabilities80.693.4568.1568.1
+ Borrowings — Current117.9156.466.066.0
+ Trade Payables82.397.163.263.2
+ Other Current Financial Liab67.837.1125.1125.1
Current Financial Liabilities268.0290.6254.3254.3
+ Provisions — Current4.25.68.68.6
+ Current Tax Liabilities0.03.83.13.1
+ Other Current Liabilities9.25.49.19.1
Current Liabilities281.5305.4275.2275.2
Total Liabilities362.1398.8843.3843.3
Total Equity & Liabilities1,171.91,281.61,823.71,823.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current1.00.90.9
+ Dues to Other Creditors — Current96.162.462.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.